PlainRecalls
FDA Devices Moderate Class II Ongoing

WALLFLEX ESOPHAGEAL FC 23/28MMX12CM- Wallflex Esophageal Partially Covered and Fully Covered Stent System is Intended for maintaining esophageal luminal patency in esophageal strictures caused by intrinsic and/or extrinsic malignant tumors, and occlusion of concurrent esophageal fistulas Material Number (UPN): M00516740

Reported: October 2, 2024 Initiated: August 1, 2024 #Z-3279-2024

Product Description

WALLFLEX ESOPHAGEAL FC 23/28MMX12CM- Wallflex Esophageal Partially Covered and Fully Covered Stent System is Intended for maintaining esophageal luminal patency in esophageal strictures caused by intrinsic and/or extrinsic malignant tumors, and occlusion of concurrent esophageal fistulas Material Number (UPN): M00516740

Reason for Recall

WallFlexTM Esophageal Stent System and AgileTM Esophageal Over the Wire (OTW) Stent System due to the potential for delivery catheter tip detachment.

Details

Units Affected
507 units
Distribution
Worldwide distribution - US Nationwide and the countries of APAC, Canada, EMEA, LATAM.
Location
Marlborough, MA

Frequently Asked Questions

What product was recalled?
WALLFLEX ESOPHAGEAL FC 23/28MMX12CM- Wallflex Esophageal Partially Covered and Fully Covered Stent System is Intended for maintaining esophageal luminal patency in esophageal strictures caused by intrinsic and/or extrinsic malignant tumors, and occlusion of concurrent esophageal fistulas Material Number (UPN): M00516740. Recalled by Boston Scientific Corporation. Units affected: 507 units.
Why was this product recalled?
WallFlexTM Esophageal Stent System and AgileTM Esophageal Over the Wire (OTW) Stent System due to the potential for delivery catheter tip detachment.
Which agency issued this recall?
This recall was issued by the FDA Devices on October 2, 2024. Severity: Moderate. Recall number: Z-3279-2024.